ACRX

AcelRX Pharmaceuticals News

Company Name Stock Ticker Symbol Market Type
AcelRX Pharmaceuticals Inc ACRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.07 3.07% 2.35 17:00:00
Open Price Low Price High Price Close Price Prev Close
2.28 2.21 2.7499 2.35 2.28
more quote information »

Recent News

Date Time Source Heading
11/22/202216:30EDGARProspectus Filed Pursuant to Rule 424(b)(7) (424b7)
11/14/202216:56EDGARQuarterly Report (10-q)
11/14/202216:19EDGARCurrent Report Filing (8-k)
11/14/202216:01PRNUSAcelRx Pharmaceuticals Reports Third Quarter 2022 Financial..
11/03/202208:30PRNUSAcelRx to Host Third Quarter 2022 Financial Results Call and..
10/31/202208:30PRNUSAcelRx Pharmaceuticals Announces Presentation of a Large..
10/27/202208:30PRNUSAcelRx Pharmaceuticals Announces the European Launch of..
10/26/202208:30PRNUSAcelRx Pharmaceuticals Announces Presentation of..
10/25/202216:52EDGARCurrent Report Filing (8-k)
10/25/202216:42PRNUSAcelRx Pharmaceuticals Announces Reverse Stock Split
10/25/202208:30PRNUSAcelRx Pharmaceuticals Announces ANESTHESIOLOGY® 2022 Annual..
9/23/202216:17EDGARCurrent Report Filing (8-k)
9/06/202216:30PRNUSAcelRx Pharmaceuticals to Participate in the H.C. Wainwright..
8/25/202208:30PRNUSAcelRx Pharmaceuticals Announces a Second Abstract on..
8/12/202216:58EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
8/12/202216:10EDGARCurrent Report Filing (8-k)
8/11/202217:02EDGARQuarterly Report (10-q)
8/11/202216:10EDGARCurrent Report Filing (8-k)
8/11/202216:01PRNUSAcelRx Pharmaceuticals Reports Second Quarter 2022 Financial..
8/11/202208:30PRNUSAcelRx Pharmaceuticals Announces Abstract Acceptance for..
8/10/202208:30PRNUSAcelRx Pharmaceuticals Announces Abstract Acceptance for..
8/04/202209:16EDGARCurrent Report Filing (8-k)
7/28/202216:50PRNUSAcelRx to Host Second Quarter 2022 Financial Results Call..
7/28/202216:08EDGARCurrent Report Filing (8-k)
7/18/202216:06EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/15/202219:36EDGARStatement of Changes in Beneficial Ownership (4)
7/15/202219:36EDGARStatement of Changes in Beneficial Ownership (4)
7/15/202219:33EDGARStatement of Changes in Beneficial Ownership (4)
7/15/202219:32EDGARStatement of Changes in Beneficial Ownership (4)
7/15/202219:30EDGARStatement of Changes in Beneficial Ownership (4)
7/15/202219:29EDGARStatement of Changes in Beneficial Ownership (4)
7/15/202219:27EDGARStatement of Changes in Beneficial Ownership (4)
6/08/202216:07EDGARStatement of Changes in Beneficial Ownership (4)
6/03/202206:06EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
6/03/202206:06EDGARProxy Statement (definitive) (def 14a)
6/02/202217:26EDGARCurrent Report Filing (8-k)
5/20/202212:49PRNUSAcelRx Pharmaceuticals to Participate in the H.C. Wainwright..
5/19/202208:30PRNUSAcelRx Pharmaceuticals Provides Update on Reduced FDA REMS..
5/16/202209:17EDGARQuarterly Report (10-q)
5/16/202207:30PRNUSAcelRx Pharmaceuticals Reports First Quarter 2022 Financial..
5/10/202208:30PRNUSAcelRx Pharmaceuticals Announces Publication of Results from..
5/09/202219:30PRNUSAcelRx to Host First Quarter 2022 Financial Results Call and..
5/09/202217:22EDGARCurrent Report Filing (8-k)
5/03/202217:24EDGARProspectus Filed Pursuant to Rule 424(b)(7) (424b7)
4/25/202208:30PRNUSMinimal Side Effects and Short Recovery Time Reported for..
4/22/202206:04EDGARSecurities Registration Statement (simplified Form) (s-3/a)
4/21/202208:30PRNUSAcelRx Pharmaceuticals Announces Upcoming Podium..
4/20/202217:15EDGARAmended Annual Report (10-k/a)
3/31/202216:10EDGARCurrent Report Filing (8-k)
3/31/202216:10PRNUSAcelRx Pharmaceuticals Announces Publication of Results from..